A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

NCT05868265 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Carcinoma

Interventions

DRUG: Enfortumab Vedotin
PROCEDURE: Radical surgery

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]